ULTY vs. THNR ETF Comparison
Comparison of YieldMax Ultra Option Income Strategy ETF (ULTY) to Amplify Weight Loss Drug & Treatment ETF (THNR)
ULTY
YieldMax Ultra Option Income Strategy ETF
ULTY Description
The fund is an actively managed exchange-traded fund that seeks current income while providing direct and/or indirect exposure to the share price of select U.S. listed securities, subject to a limit on potential investment gains. It uses both traditional and synthetic covered call strategies that are designed to produce higher income levels when the underlying securities experience more volatility. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$9.98
Average Daily Volume
797,532
18
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$25.33
Average Daily Volume
2,814
15
Performance
| Period | ULTY | THNR |
|---|---|---|
| 30 Days | 5.18% | -4.66% |
| 60 Days | 4.99% | -10.17% |
| 90 Days | 13.65% | -2.39% |
| 12 Months |
1 Overlapping Holdings
| Symbol | Grade | Weight in ULTY | Weight in THNR | Overlap | |
|---|---|---|---|---|---|
| VKTX | A | 3.22% | 2.43% | 2.43% |
ULTY: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords
Compare ETFs
